Proposal calls for monitoring of CSMP by pharmacists

Introduced by 11 members of the WV House of Delegates, House Bill 4183 requires pharmacists to continually monitor the West Virginia Controlled Substance Monitoring Program (CSMP), maintained by the Board of Pharmacy, to determine whether any of his or her clients (patients) have overdosed on a prescription filled by the pharmacist.   If so, the pharmacist shall immediately notify the doctor who prescribed the medications.

Delegates introducing the proposed law are: Chris Stansbury (R-Kanawha), Matthew Rohrbach (R-Cabell), Don Perdue (D-Wayne), Randy Smith (R-Preston), Denise Campbell (D-Randolph), Mick Bates (D-Raleigh), Brad White (R-Kanawha), Ryan Weld (R-Brooke), John McCusky (R-Kanawha), Steve Westfall (R-Jackson) and Joe Ellington (R-Mercer).

The proposed law also amends the current Controlled Substances Monitoring law, Chapter 60-9-4, by requiring emergency medical service agencies or emergency medical service provider who treats or responds to an individual who has suffered an opioid overdose to report to the Board of Pharmacy’s Controlled Substance Monitoring Program the following information: the full legal name, address and date of birth of the person for whom the prescription is written; the name, address, pharmacy prescription number and DEA opioid registration number of the dispensing pharmacy or dispensing physician or dentist; name, address and DEA opioid registration number of the practitioner writing the prescription; name and NDC number of the opioid dispensed; the quantity and dosage of the opioid dispensed; and the date the prescription was written and the date filled.